Tel Aviv University’s Advances In Medicine
Students who are accepted into our program, which is taught in English, are at the center of medical breakthroughs that have placed TAU and Israel among the world’s pre-eminent leaders in advances in medicine and biotechnology.
Tel Aviv University’s multidisciplinary nanotechnology center is at the forefront of global research and development. Among the many exciting research projects underway is the development of a built-in navigation system using nano-gyroscopes for the PillCam®, which was developed in Israel.
Other TAU advances in medicine include the discovery of differentiated mesenchymal cells (MSC). Researchers are now studying the use of mesenchymal stem cells in-vivo MRI to treat neurodegenerative diseases. TAU researchers also developed Circadin®, a new drug that mimics melatonin, which helps combat insomnia in people over 55. Available in Europe and Australia, Circadin® is awaiting FDA approval. TAU and New York University researchers have developed a modified MRI technology that provides a non-invasive early diagnosis of osteoarthritis and spinal disc degeneration. TAU researchers also developed a radioactive wire that irradiates tumors from the inside out and releases antigens that trigger an immune response against the cancerous cells. It will soon undergo clinical trials. The first early-warning test that can detect colon cancer in the blood using biomarkers that can detect cells of colon polyps in the blood in 80 percent of
Students who are accepted into our program are at the center of medical breakthroughs …
patients is yet another TAU discovery. TAU’s physicians, scientists and researchers are continuing to make vitally important contributions to medicine worldwide. The students at the American Medical Program at Tel Aviv University have the unique opportunity to learn from the best and experience the latest advances in medicine. It is hardly surprising that our graduates have gone on to achieve such impressive careers.
